Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1145541

	registered interest
	date	24/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the UK leaving the EU without a deal on access to epilepsy medication.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	290454
	answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. Our plans should ensure the supply of medicines and medical products when we leave the EU on 31 October.</p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medicines, to the whole of the UK and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 16:50:47 answering member 4362 label Biography information for Edward Argar
	tabling member	4510 label Biography information for Helen Hayes

1145542

	registered interest
	date	24/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect on access to cancer treatment of the UK leaving the EU without an agreement.
	tabling member constituency	Dulwich and West Norwood
	tabling member printed	Helen Hayes
	uin	290455
	answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. Our plans should ensure the supply of medicines and medical products when we leave the EU on 31 October.</p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medical products to the whole of the UK and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>As with our plans leading up to 29<sup> </sup>March, for those medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes for use in the diagnosis and treatment of cancer, we have asked suppliers to make alternative arrangements, using air freight, which some suppliers are already doing now. We have offered support to companies to arrange this.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 16:54:34 answering member 4362 label Biography information for Edward Argar
	tabling member	4510 label Biography information for Helen Hayes

1145575

	registered interest
	date	24/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Capital Investment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many bids for capital spending (a) his Department, (b) NHS England and (c) NHS Improvement has (i) rejected and (ii) not responded to in each of the last five years; and what the total value was of the bids (A) rejected and (B) not responded to in each of the last five years.
	tabling member constituency	High Peak
	tabling member printed	Ruth George
	uin	290466
	answer	answer is ministerial correction date of answer 02/10/2019 answer text <p>The information requested on capital bids received by the Department and NHS England and NHS Improvement for capital spending are not held centrally and could only be obtained at disproportionate cost.</p><p>There have been a multitude of capital funds in the last five years varying in value, complexity and outcome objective and NHS England and NHS Improvement are in on-going discussions with trusts about their capital needs and plans.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 290467 question first answered 02/10/2019 12:17:49 answering member 4362 label Biography information for Edward Argar
	tabling member	4662 label Biography information for Ruth George

1145761

	registered interest
	date	25/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department is rationing the supply of medical isotopes in advance of the UK potentially leaving the EU without a deal; and what steps he is taking to ensure an adequate supply of medical isotopes in the event that the UK leaves the EU without a deal.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	291038
	answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. Our plans should ensure the supply of medicines and medical products, including medical radioisotopes, when we leave the EU on 31 October.</p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medical products, including medical radioisotopes, to the whole of the UK and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>As with our plans leading up to 29 March, for those medicines that cannot be stockpiled because, for example, they have short shelf-lives, such as medical radioisotopes for use in the diagnosis and treatment of cancer, we have asked suppliers to make alternative arrangements, using airfreight, which some suppliers are already doing. We have offered support to companies to arrange this and are actively working with suppliers to ensure detailed plans are in place ahead of the 31 October.</p><p><strong> </strong></p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 16:52:16 answering member 4362 label Biography information for Edward Argar
	tabling member	4523 label Biography information for Catherine West

1145762

	registered interest
	date	25/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Hormone Replacement Therapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the supply of HRT patches; and whether stock levels of HRT patches have been affected by uncertainty over the UK's departure from the EU.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	291039
	answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department fully understands that maintaining access to hormone replacement therapy (HRT) medications is vitally important to many people in this country.</p><p>We are aware of ongoing supply issues with some HRT transdermal patches due to manufacturing issues. We have been working closely with all suppliers of HRT transdermal patches to maintain overall supply to patients. Although some HRT transdermal patches are affected by supply issues, supplies of other alternative HRT transdermal patches have remained available.</p><p>We continue to work with all stakeholders to ensure relevant information about the HRT products affected by supply issues and the products that remain available is shared across the National Health Service on a regular basis. We have already issued comprehensive communications to the NHS with regard to availability and signposted clinicians to sources they can use to support local decision making around switching patients who are affected by the current supply disruptions.</p><p> </p><p>We will continue to work directly with all suppliers of the affected and alternative products to resolve the supply issues as soon as possible and ensure supplies of HRT products including transdermal patches continue to remain available.</p><p><strong> </strong></p><p>There is no evidence that the small number of current HRT supply issues we are managing are related to EU exit or increasing because of this.</p><p><strong> </strong></p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 14:00:36 answering member 4362 label Biography information for Edward Argar
	tabling member	4523 label Biography information for Catherine West

1145832

	registered interest
	date	25/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to Operation Yellowhammer HMG Reasonable Worst Case Planning Assumptions paragraph 6, what steps his Department is taking to ensure the (a) geographically equitable and (b) economically equitable distributions of medicines in limited supply in the event of the UK leaving the EU without a deal.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	290702
	answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. Our plans should ensure the supply of medicines and medical products when we leave the EU on 31 October.</p><p> </p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medicines to the whole of the UK and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 16:53:40 answering member 4362 label Biography information for Edward Argar
	tabling member	534 label Biography information for Chris Ruane

1145954

	registered interest
	date	25/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Business Services Authority: North East and North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 September 2019 to Question 285061, how many offices the NHS Business Service Authority has in the (a) North East and (b) North West.
	tabling member constituency	Wallasey
	tabling member printed	Ms Angela Eagle
	uin	290694
	answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>In the north west of England, the NHS Business Services Authority currently occupies three properties, two offices and one warehouse.</p><p>In the north east of England, NHS Business Services Authority currently occupies four properties, two offices and two warehouses, and manages one property on behalf of the Counter Fraud Authority.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 13:58:25 answering member 4362 label Biography information for Edward Argar
	tabling member	491 label Biography information for Dame Angela Eagle

1145993

	registered interest
	date	25/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Billing
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of invoices received by the NHS are paid within 30 days; and how many incur 29 per cent interest for late payment of more than 30 days.
	tabling member constituency	Poplar and Limehouse
	tabling member printed	Jim Fitzpatrick
	uin	290600
	answer	answer is ministerial correction date of answer 02/10/2019 answer text <p>The Department does not centrally collect or hold performance payment data for the National Health Service. NHS trusts and NHS foundation trusts are required to follow the Public Contracts Regulations 2015 (PCR 2015) which states contracting authorities must pay valid and undisputed invoices within 30 days.</p><p> </p><p>NHS Improvement monitors Better Payments Practice Code performance data on a monthly basis. Page 47 of the Departmental annual report shows an improvement in the percentage of invoices paid within target from 77% (2017-18) to 79% (2018-19). The report is available at the following link:</p><p><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/832765/dhsc-annual-report-and-accounts-2018-to-2019.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/832765/dhsc-annual-report-and-accounts-2018-to-2019.pdf</a></p><p>The Department does not hold information on how many invoices incur the 29% late payment interest.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 02/10/2019 11:25:05 answering member 4362 label Biography information for Edward Argar
	tabling member	197 label Biography information for Jim Fitzpatrick

1146078

	registered interest
	date	25/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of (a) his Department's and (b) others liability should medicine shortages, outlined in the Yellowhammer document, lead to preventable deaths.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	290580
	answer	answer is ministerial correction date of answer 30/09/2019 answer text <p>The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. Our plans should ensure the supply of medicines and medical products when we leave the EU on 31 October.</p><p>The Department, in consultation with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system in England to make detailed plans that should ensure continuation of the supply of medicines to the whole of the UK and its Crown Dependencies.</p><p> </p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 30/09/2019 16:53:00 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1146140

	registered interest
	date	25/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	York Teaching Hospital NHS Foundation Trust: Capital Investment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what capital expenditure York Teaching Hospital NHS Foundation Trust has incurred in each year since 2005-06.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	290948
	answer	answer is ministerial correction date of answer 02/10/2019 answer text <p>The available information is shown in the following table.</p><table><tbody><tr><td><p>Financial year</p></td><td><p>Intangibles £'000</p></td><td><p>Property, Plant and Equipment £'000</p></td><td><p>Total<br> £'000</p></td></tr><tr><td><p>2010-11</p></td><td><p>609</p></td><td><p>9,839</p></td><td><p>10,448</p></td></tr><tr><td><p>2011-12</p></td><td><p>236</p></td><td><p>4,148</p></td><td><p>4,384</p></td></tr><tr><td><p>2012-13</p></td><td><p>31</p></td><td><p>11,229</p></td><td><p>11,260</p></td></tr><tr><td><p>2013-14</p></td><td><p>1,137</p></td><td><p>15,278</p></td><td><p>16,415</p></td></tr><tr><td><p>2014-15</p></td><td><p>269</p></td><td><p>21,377</p></td><td><p>21,646</p></td></tr><tr><td><p>2015-16</p></td><td><p>78</p></td><td><p>18,096</p></td><td><p>18,174</p></td></tr><tr><td><p>2016-17</p></td><td><p>528</p></td><td><p>13,400</p></td><td><p>13,928</p></td></tr><tr><td><p>2017-18</p></td><td><p>633</p></td><td><p>17,388</p></td><td><p>18,021</p></td></tr><tr><td><p>2018-19</p></td><td><p>1,262</p></td><td><p>21,702</p></td><td><p>22,964</p></td></tr></tbody></table><p>Source: NHS Improvement</p><p>Capital expenditure is a broad term. For this response it is defined as being purchases of owned property, plant and equipment and intangible assets on an accruals basis.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 02/10/2019 11:31:09 answering member 4362 label Biography information for Edward Argar
	tabling member	4471 label Biography information for Rachael Maskell